Sumatriptan Injection, Solution
Product Images NDC 83270-005

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 83270-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Onesource Specialty Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (Carton Label)

This text mentions "O VARNISH 20N" which might be a product name or type. Additionally, it refers to "tan Injection, USP" which could indicate a type of medical injection. The rest of the text seems unclear and may not provide any substantial information.*

FDA Label Image

Foil-label (Foil Label)

This text provides details about Sumatriptan Injection, USP, with a concentration of 6 mg per 0.5 mL for subcutaneous injection. It emphasizes discarding unused portions and storing between 2°C and 30°C. The solution contains 8.4 mg of sumatriptan succinate, equivalent to 6 mg of sumatriptan, and 35 mg of Sodium chloride. The information also advises storing away from light and following specific dosage and administration instructions provided by a healthcare professional.*

FDA Label Image

Structure (Image 01)

FDA Label Image

Figure 1 (Image 02)

This chart shows the time to relief of cluster headache from the time of injection. It compares the effectiveness of a placebo (N=127) versus Sumatriptan (N=131) in providing relief to patients. The percentage of patients experiencing relief over time is displayed on the graph.*

FDA Label Image

Instruction For Use (Instruction For Use)

This text provides detailed instructions on how to use Sumatriptan Injection with a prefilled syringe, emphasizing the correct technique for subcutaneous injection. The text includes information about the BD UltraSafe Plus™ Passive Needle Guard system, components of the system, proper administration techniques, site selection, preparation, injection process, inspection of the syringe, disposal of the syringe/needle guard assembly, and ensuring the medication is not expired. It also mentions the importance of proper disposal of needles, syringes, and unused medications, and emphasizes that the syringe/needle guard assembly is for one-time use only.*

FDA Label Image

Vial Label (Pfs Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.